Private Advisor Group, LLC Infinity Pharmaceuticals, Inc. Transaction History

Private Advisor Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$0.59 - $1.7 $2,065 - $5,950	-3,500 Reduced 8.03%	40,100 $48,000
Q2 2022 Jul 13, 2022	BUY	$0.49 - $1.2 $490 - $1,200	1,000 Added 2.35%	43,600 $28,000
Q1 2022 May 12, 2022	BUY	$0.85 - $2.4 $7,735 - $21,840	9,100 Added 27.16%	42,600 $49,000
Q4 2021 Feb 10, 2022	SELL	$1.86 - $3.36 $31,620 - $57,120	-17,000 Reduced 33.66%	33,500 $75,000
Q3 2021 Oct 14, 2021	BUY	$1.52 - $3.82 $57,760 - $145,160	38,000 Added 304.0%	50,500 $173,000
Q1 2021 Apr 22, 2021	BUY	$1.98 - $5.36 $24,750 - $67,000	12,500 New	12,500 $40,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.